血清生長(zhǎng)分化因子-15與N末端B型利鈉肽原聯(lián)合檢測(cè)在心肺復(fù)蘇成功后患者近期預(yù)后評(píng)估中應(yīng)用價(jià)值的研究
[Abstract]:Aim: to investigate the value of combined detection of serum growth differentiation factor-15 (GDF-15) and N-terminal B-type natriuretic peptide (NT-pro BNP) in evaluating the short-term prognosis of patients after successful cardiopulmonary resuscitation (CPR). Methods: a total of 102 CPR patients with cardiac arrest in our hospital were selected. Serum GDF-15 levels were measured immediately, 12 h, and 24 h after CPR, and were divided into 3 groups according to the time when the serum GDF-15 level increased. Group A (31 cases immediately after): CPR) was divided into 3 groups: group A (n = 31), and group A (n = 31). 12 h and 24 h 48 h serum GDF-15 levels remain at 1200 ng/L; The level of serum GDF-15 in group B (n = 35) was higher than that in group B (n = 35) at 12 h and 24 h after): CPR, and the serum GDF-15 level in group B (n = 36) was higher than that in group B (n = 36) at 12 h and 24 h after): CPR (n = 36), but decreased at 24 h (P < 0. 05). At the same time, the levels of serum NT-pro BNP and left ventricular ejection fraction (LVEF).) were measured at different time points in three groups. All patients were followed up for 6 months after CPR. Results: there was interaction between serum GDF-15 and NT-pro BNP (P0.05), that is, the expression level of NT-pro BNP changed with the change of serum GDF-15 level, and there was a negative correlation between serum GDF-15 and LVEF (r = 0.530, P0.001). The mortality of patients with high expression of serum GDF-15 (1800 ng/L) and high expression of serum NTpro BNP (400 pg/ml) was higher than that of those with low expression of serum GDF-15,NT-pro BNP (P0.05). The results of survival analysis showed that the 6-month survival rate of group B was lower than that of group A and C (P0.05); A group and C group, there was no significant difference (P0.05). Conclusion: the combined detection of serum GDF-15 and NT-pro BNP can predict the short-term clinical prognosis of CPR patients.
【作者單位】: 承德市中心醫(yī)院急診科;
【基金】:承德市科學(xué)技術(shù)研究與發(fā)展計(jì)劃項(xiàng)目(20142009)
【分類號(hào)】:R459.7
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 馬虹;;重組人B型利鈉肽:急性失代償性心力衰竭治療的重大進(jìn)展[J];嶺南心血管病雜志;2005年06期
2 張孝欽;王興祥;丁晨彥;曾蕾;;B型利鈉肽在心源性和肺源性急性呼吸困難鑒別中的應(yīng)用價(jià)值[J];臨床薈萃;2006年02期
3 戴華;莫艷波;肖文良;張小梅;武彩娥;;B型利鈉肽和左室舒張功能障礙關(guān)系的研究[J];中國(guó)醫(yī)師進(jìn)修雜志;2006年07期
4 馬虹;;重組人B型利鈉肽治療急性失代償性心力衰竭[J];中華老年心腦血管病雜志;2006年04期
5 丁宇;陳倩;張麗;楊庭樹;;老年舒張性心力衰竭患者血清促甲狀腺激素與B型利鈉肽的關(guān)系[J];中國(guó)康復(fù)理論與實(shí)踐;2010年03期
6 劉紅櫻;王蔚;葛均波;;B型利鈉肽與急性冠狀動(dòng)脈綜合征的研究進(jìn)展[J];上海醫(yī)學(xué);2011年03期
7 楊紅群;;新生兒吸入性肺炎合并心衰B型利鈉肽檢測(cè)的臨床價(jià)值[J];當(dāng)代醫(yī)學(xué);2013年11期
8 陳銳;毛一歆;任坤;岳凡;葉人誦;錢儼;;N末端B型利鈉肽原在老年慢性心力衰竭患者治療評(píng)估作用研究[J];醫(yī)藥論壇雜志;2013年07期
9 王如興,李肖蓉,邵力正,羊鎮(zhèn)宇,肖春暉,王強(qiáng),楊光敏;B型利鈉肽對(duì)心源性和非心源性呼吸困難鑒別診斷界值標(biāo)準(zhǔn)研究[J];實(shí)用心腦肺血管病雜志;2004年05期
10 鐘梁;鄭放超;何玲玲;張燕;張俊琦;劉蓉;;B型利鈉肽與老年慢性心力衰竭的相關(guān)性研究[J];西南國(guó)防醫(yī)藥;2009年10期
相關(guān)會(huì)議論文 前10條
1 張建義;黃文新;陽(yáng)躍中;潘迪華;莫新玲;夏中華;徐彤彤;;老年充血性心力衰竭患者B型利鈉肽前體濃度與長(zhǎng)期預(yù)后的關(guān)系[A];中華醫(yī)學(xué)會(huì)心血管病學(xué)分會(huì)第八次全國(guó)心血管病學(xué)術(shù)會(huì)議匯編[C];2006年
2 陳作強(qiáng);趙仙先;秦永文;陳少萍;;血漿B型利鈉肽對(duì)老年急性冠狀動(dòng)脈綜合征介入治療患者的臨床預(yù)后[A];第十三次全國(guó)心血管病學(xué)術(shù)會(huì)議論文集[C];2011年
3 郜攀;黃嵐;郭瑞威;;B型利鈉肽對(duì)小鼠腹腔巨噬細(xì)胞單核細(xì)胞趨化因子-1蛋白表達(dá)的雙向調(diào)節(jié)作用[A];中華醫(yī)學(xué)會(huì)第11次心血管病學(xué)術(shù)會(huì)議論文摘要集[C];2009年
4 陳牧雷;徐立;于麗萍;李奎寶;孫昊;趙曉濤;李強(qiáng);張婧;王U,
本文編號(hào):2435935
本文鏈接:http://sikaile.net/huliyixuelunwen/2435935.html